Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Guardant Health, Inc.    GH

GUARDANT HEALTH, INC.

(GH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/29/2020 07/30/2020 07/31/2020 08/03/2020 08/04/2020 Date
84.15(c) 86.03(c) 85.18(c) 86.02(c) 84.52(c) Last
553 411 528 530 382 277 590 348 572 586 Volume
+1.85% +2.23% -0.99% +0.99% -1.74% Change
More quotes
Financials (USD)
Sales 2020 279 M - -
Net income 2020 -131 M - -
Net Debt 2020 - - -
P/E ratio 2020 -61,6x
Yield 2020 -
Sales 2021 375 M - -
Net income 2021 -113 M - -
Net Debt 2021 - - -
P/E ratio 2021 -73,2x
Yield 2021 -
Capitalization 8 358 M 8 358 M -
Capi. / Sales 2020 30,0x
Capi. / Sales 2021 22,3x
Nbr of Employees 622
Free-Float 91,4%
More Financials
Company
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection, LUNAR-1 and... 
More about the company
Surperformance© ratings of Guardant Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on GUARDANT HEALTH, INC.
07/30Guardant Health Announces Collaboration with Radius Health to Develop Liquid ..
GL
07/21Guardant Health Announces Webcast of Second Quarter Financial Results on Augu..
GL
07/08Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy..
GL
06/23Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate P..
GL
06/22Guardant Health Presents Data at AACR Virtual Annual Meeting II Showing Liqui..
GL
06/16GUARDANT HEALTH, INC. : Change in Directors or Principal Officers, Financial Sta..
AQ
06/16Guardant Health Appoints Vijaya Gadde to its Board of Directors
GL
06/15GUARDANT HEALTH, INC. : Submission of Matters to a Vote of Security Holders (for..
AQ
06/08Guardant Health Announces Full Exercise of Option and Closing of Public Offer..
GL
06/04GUARDANT HEALTH, INC. : Other Events (form 8-K)
AQ
06/01GUARDANT HEALTH : Announces Pricing of Upsized Public Offering
AQ
06/01Guardant Health Announces Proposed Public Offering of Common Stock
GL
05/29GUARDANT HEALTH : to Participate in the William Blair 2020 Growth Stock Conferen..
AQ
05/27GUARDANT HEALTH, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
05/15Guardant Health Data at ASCO and AACR Demonstrates Growing Value of Liquid Bi..
GL
More news
News in other languages on GUARDANT HEALTH, INC.
07/30Guardant Health Announces Collaboration with Radius Health to Develop Liquid ..
07/21Guardant Health Announces Webcast of Second Quarter Financial Results on Augu..
07/08Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy..
06/23Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate P..
06/22Guardant Health Presents Data at AACR Virtual Annual Meeting II Showing Liqui..
More news
Stock Trading Strategies
GUARDANT HEALTH, INC. - 07/30
The upward trend should continue
BUY
More Stock Trading Analysis
Chart GUARDANT HEALTH, INC.
Duration : Period :
Guardant Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUARDANT HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 111,25 $
Last Close Price 84,52 $
Spread / Highest target 53,8%
Spread / Average Target 31,6%
Spread / Lowest Target 6,48%
EPS Revisions
Managers
NameTitle
Helmy Eltoukhy Chief Executive Officer & Director
AmrAli H. Talasaz Chairman, President & Chief Operations Officer
Derek A. Bertocci Chief Financial Officer
Kumud Kalia Chief Information Officer
Darya Chudova Senior Vice President-Technology
Sector and Competitors
1st jan.Capitalization (M$)
GUARDANT HEALTH, INC.8.16%8 358
EXACT SCIENCES CORPORATION0.50%13 957
SEEGENE INC--.--%6 013
ADAPTIVE BIOTECHNOLOGIES CORPORATION34.49%5 402
IOVANCE BIOTHERAPEUTICS, INC.11.16%4 503
INVITAE CORPORATION105.27%4 139